Title:
COMPOSITION FOR PREVENTING OR TREATING HEPATIC FIBROSIS, COMPRISING BETA-GUANIDINOPROPIONIC ACID
Document Type and Number:
WIPO Patent Application WO/2023/063663
Kind Code:
A1
Abstract:
The present invention relates to a composition comprising a beta-guanidinopropionic acid (β-GPA), and a use thereof for preventing or treating hepatic fibrosis.
Inventors:
YI HYON SEUNG (KR)
SHONG MINHO (KR)
SHONG MINHO (KR)
Application Number:
PCT/KR2022/015198
Publication Date:
April 20, 2023
Filing Date:
October 07, 2022
Export Citation:
Assignee:
HUENCHEM CO LTD (KR)
International Classes:
A61K31/155; A23L33/10; A61P1/16; A61P43/00
Domestic Patent References:
| WO2014071067A2 | 2014-05-08 |
Foreign References:
| US20210177790A1 | 2021-06-17 | |||
| KR20180059446A | 2018-06-04 | |||
| KR100190257B1 | 1999-06-01 |
Other References:
CROCKER CHELSEA L.; BAUMGARNER BRADLEY L.; KINSEY STEPHEN T.: "β-guanidinopropionic acid and metformin differentially impact autophagy, mitochondria and cellular morphology in developing C2C12 muscle cells", JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY., CHAPMAN, LONDON., GB, vol. 41, no. 2-3, 13 December 2019 (2019-12-13), GB , pages 221 - 237, XP037292347, ISSN: 0142-4319, DOI: 10.1007/s10974-019-09568-0
Attorney, Agent or Firm:
B&IP-JOOWON PATENT AND LAW FIRM (KR)
Download PDF: